Clearmind Medicine (CMND) Cash from Financing Activities (2022 - 2026)
Clearmind Medicine (CMND) reported Cash from Financing Activities of $3.34 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), compared with -$10,812 a year earlier and down 27.1% from the prior quarter.
Powered by 
Analysis
Clearmind Medicine (CMND) Cash from Financing Activities (2022 - 2026) Analysis & Trends
Over the twelve months ended Jul 31, 2026, Clearmind Medicine's Cash from Financing Activities came in at $17.57 million; for FY2025 (ended Oct 31, 2025), it was $2.62 million, down 58.1% from FY2024.
- Cash from Financing Activities has a five-year compound annual growth rate of 42.6% (FY2020 to FY2025).
- By fiscal year, Cash from Financing Activities came in at $6.25 million in FY2024 (-46.4%), $11.66 million in FY2023, $511,688 in FY2022 (-90.5%) and $5.39 million in FY2021.
- Five-year quarterly Cash from Financing Activities spans a low of -$69,033 in fiscal Q4 2022 and a high of $7.42 million in fiscal Q1 2026.
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $4.58 million (Q2 2026), $7.42 million (Q1 2026) and $2.24 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | -8.78 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | -3.89 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -3.66 Bn |
| 10 | Clearmind Medicine | 9,526.05 | -39.89 Mn | - | 3.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 3.34 Mn |
| Apr 30, 2026 | 4.58 Mn |
| Jan 31, 2026 | 7.42 Mn |
| Oct 31, 2025 | 2.24 Mn |
| Jul 31, 2025 | -10,812.00 |
| Apr 30, 2025 | -10,298.00 |
| Jan 31, 2025 | 404,812.00 |
| Oct 31, 2024 | 323,205.00 |
| Jul 31, 2024 | 469,537.00 |
| Apr 30, 2024 | 145,129.00 |
| Jan 31, 2024 | 5.32 Mn |
| Oct 31, 2023 | 2.41 Mn |
| Jul 31, 2023 | -31,686.00 |
| Apr 30, 2023 | 2.94 Mn |
| Jan 31, 2023 | 6.35 Mn |
| Oct 31, 2022 | -69,033.00 |
| Jul 31, 2022 | -48,286.00 |
API Access
Clearmind Medicine Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=CMND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "CMND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=CMND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();